2024-09-272024-09-272023-03-011308-5727https://doi.org/10.4274/jcrpe.galenos.2021.2021.0121https://hdl.handle.net/11452/45362Persistent hypoglycemia in infants with congenital hyperinsulinism (CHI) can be challenging in approximately half of these cases, even after undergoing a near-total pancreatectomy. While maltodextrin has been recommended in the nutritional management of CHI cases younger than six months, information regarding its efficacy in managing hypoglycemia are not yet clear. Here, we present a male infant with CHI who experienced persistent hypoglycemia even after undergoing a near-total pancreatectomy and despite multiple medical treatments. The infant's hypoglycemic episodes were successfully controlled by adding maltodextrin to his diet.eninfo:eu-repo/semantics/closedAccessDiagnosisManagementCongenital hyperinsulinismAbcc8 geneMaltodextrinNear -total pancreatectomyContinue glucose monitoring systemsScience & technologyLife sciences & biomedicineEndocrinology & metabolismEndocrinology & metabolismPediatricsMaltodextrin may be a promising treatment modality after near-total pancreatectomy in infants younger than six months with persistent hyperinsulinism: A case reportArticle00093826320001510310715110.4274/jcrpe.galenos.2021.2021.0121